Envisagenics
Private company
ENVISAGENICS
RNA Splicing Analytics + Artificial Intelligence for Drug Discovery.
Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. Envisagenics is Cold Spring Harbor Laboratory spinout company.
Founded
2014
2014
Status
Private company
Private company
Geography
United States of America based
United States of America based
Funding
$4.575 M
$4.575 M
Website
https://www.envisagenics.com/
https://www.envisagenics.com/
Research papers
3
3
Products
SpliceCore
Artificial Intelligence Platform for Drug Discovery
SpliceCore™ is the Envisagenics cloud-based drug discovery platform that uses RNA data from patients to accelerate R&D therapeutics discovery using …
Services
No services posted yet
This data is part of our proprietary analytics report:
- A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D
- RNA-focused Startups